“The health of our citizens depends on the availability of safe, effective and affordable medicines. In the future, pharmaceutical manufacturing will need to employ innovation, cutting edge scientific and engineering knowledge […]”
(Innovation and Continuous Improvement in Pharmaceutical Manufacturing – FDA).
How to leverage innovation and knowledge in your company
For many global companies, managing and sharing knowledge is not an easy task. Local pockets of excellence and lack of overview lead to frustration, duplication of effort and missing alignment. Empowering employees through harnessing internal drive for innovation is the key to success. However, managing internal innovation and knowledge is not only top-down but requires a bottom-up approach. How can we achieve this?
Dr. Michelangelo Canzoneri, global head of technology & innovation for therapeutic proteins at Sanofi, has developed a possible solution: BITMAP. The BITMAP platform has been launched last year and awarded as Young Industrial Talent by Philippe Luscan, SVP Industrial Affairs and Olivier Brandicourt, CEO of Sanofi.
BITMAP stands for Biologics Innovation and Technology MAnagement Process and is composed of three different elements: People, Business Process and IT-Platform. It builds a sustainable global network of experts, to harmonize the evaluation and implementation of strategic technologies during development and manufacturing of (bio)pharmaceutical drugs.
To find out more about knowledge management, join us and Dr. Michelangelo Canzoneri in our free Webinar on October 18th at 5pm (UTC +2).
Dr. Michelangelo Canzoneri holds a PhD in Bioprocess Engineering, graduated from the faculty of Technology / Cell Culture Technology, Bielefeld University in 2012. He started his career in 2003 at Kourion Therapeutics / ViaCell Inc. responsible for Quality Control of adult stem cells. In 2008 he joined Sanofi R&D as Laboratory Head Upstream Process Development responsible for small and large scale manufacturing of cell cultured based drugs from pre-clinic to clinical phase III. His current role at Sanofi is Global Head of Technology and Innovation Therapeutic Proteins, Corporate Biologics. As a university lecturer in Frankfurt (Germany) and a guest lecturer at the MIT in Boston (USA) he is strongly engaged and motivated in building the interface between academia and BioPharma Industry. Since 2016, he chairs the transversal team of the EU SIG Biotech and supports the integration of ISPE YP in all Pharma/Workforce 4.0 related topics.
The Webinar is free of charge.
The Webinar will be held in english.
Register here to receive link and access code.
The Webinar will be limited to 25 participants.
YP's absolutely preferred.
With many thanks to the Team and the Speakers,
Takeda Pharmaceuticals International AG
Chair ISPE D/A/CH